Medical Care
Global Agoraphobia Market Research Report 2024
- Jan 20, 24
- ID: 19678
- Pages: 72
- Figures: 137
- Views: 39
Agoraphobia (ag-uh-ruh-FOE-be-uh) is a type of anxiety disorder in which you fear and avoid places or situations that might cause you to panic and make you feel trapped, helpless or embarrassed.
The global Agoraphobia market was valued at US$ 607.2 million in 2023 and is anticipated to reach US$ 740.8 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
North American market for Agoraphobia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Agoraphobia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Agoraphobia in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Agoraphobia include Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Pfizer, GlaxoSmithKline, Johnson&Johnson, Sandoz, Apotex and Mylan Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Agoraphobia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Agoraphobia.
Report Scope
The Agoraphobia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Agoraphobia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Agoraphobia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Pfizer
GlaxoSmithKline
Johnson&Johnson
Sandoz
Apotex
Mylan Pharmaceuticals
Segment by Type
Selective Serotonin Reuptake Inhibitors
Norepinephrine Reuptake Inhibitors
Others
Segment by Application
Hospitals
Private clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Agoraphobia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Agoraphobia market was valued at US$ 607.2 million in 2023 and is anticipated to reach US$ 740.8 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
North American market for Agoraphobia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Agoraphobia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Agoraphobia in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Agoraphobia include Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Pfizer, GlaxoSmithKline, Johnson&Johnson, Sandoz, Apotex and Mylan Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Agoraphobia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Agoraphobia.
Report Scope
The Agoraphobia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Agoraphobia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Agoraphobia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Pfizer
GlaxoSmithKline
Johnson&Johnson
Sandoz
Apotex
Mylan Pharmaceuticals
Segment by Type
Selective Serotonin Reuptake Inhibitors
Norepinephrine Reuptake Inhibitors
Others
Segment by Application
Hospitals
Private clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Agoraphobia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Agoraphobia Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Selective Serotonin Reuptake Inhibitors
1.2.3 Norepinephrine Reuptake Inhibitors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Agoraphobia Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Private clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Agoraphobia Market Perspective (2019-2030)
2.2 Agoraphobia Growth Trends by Region
2.2.1 Global Agoraphobia Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Agoraphobia Historic Market Size by Region (2019-2024)
2.2.3 Agoraphobia Forecasted Market Size by Region (2025-2030)
2.3 Agoraphobia Market Dynamics
2.3.1 Agoraphobia Industry Trends
2.3.2 Agoraphobia Market Drivers
2.3.3 Agoraphobia Market Challenges
2.3.4 Agoraphobia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Agoraphobia Players by Revenue
3.1.1 Global Top Agoraphobia Players by Revenue (2019-2024)
3.1.2 Global Agoraphobia Revenue Market Share by Players (2019-2024)
3.2 Global Agoraphobia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Agoraphobia Revenue
3.4 Global Agoraphobia Market Concentration Ratio
3.4.1 Global Agoraphobia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Agoraphobia Revenue in 2023
3.5 Agoraphobia Key Players Head office and Area Served
3.6 Key Players Agoraphobia Product Solution and Service
3.7 Date of Enter into Agoraphobia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Agoraphobia Breakdown Data by Type
4.1 Global Agoraphobia Historic Market Size by Type (2019-2024)
4.2 Global Agoraphobia Forecasted Market Size by Type (2025-2030)
5 Agoraphobia Breakdown Data by Application
5.1 Global Agoraphobia Historic Market Size by Application (2019-2024)
5.2 Global Agoraphobia Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Agoraphobia Market Size (2019-2030)
6.2 North America Agoraphobia Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Agoraphobia Market Size by Country (2019-2024)
6.4 North America Agoraphobia Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Agoraphobia Market Size (2019-2030)
7.2 Europe Agoraphobia Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Agoraphobia Market Size by Country (2019-2024)
7.4 Europe Agoraphobia Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Agoraphobia Market Size (2019-2030)
8.2 Asia-Pacific Agoraphobia Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Agoraphobia Market Size by Region (2019-2024)
8.4 Asia-Pacific Agoraphobia Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Agoraphobia Market Size (2019-2030)
9.2 Latin America Agoraphobia Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Agoraphobia Market Size by Country (2019-2024)
9.4 Latin America Agoraphobia Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Agoraphobia Market Size (2019-2030)
10.2 Middle East & Africa Agoraphobia Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Agoraphobia Market Size by Country (2019-2024)
10.4 Middle East & Africa Agoraphobia Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Agoraphobia Introduction
11.1.4 Eli Lilly Revenue in Agoraphobia Business (2019-2024)
11.1.5 Eli Lilly Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Detail
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Agoraphobia Introduction
11.2.4 Bristol-Myers Squibb Revenue in Agoraphobia Business (2019-2024)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Agoraphobia Introduction
11.3.4 AstraZeneca Revenue in Agoraphobia Business (2019-2024)
11.3.5 AstraZeneca Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Agoraphobia Introduction
11.4.4 Pfizer Revenue in Agoraphobia Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Agoraphobia Introduction
11.5.4 GlaxoSmithKline Revenue in Agoraphobia Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Johnson&Johnson
11.6.1 Johnson&Johnson Company Detail
11.6.2 Johnson&Johnson Business Overview
11.6.3 Johnson&Johnson Agoraphobia Introduction
11.6.4 Johnson&Johnson Revenue in Agoraphobia Business (2019-2024)
11.6.5 Johnson&Johnson Recent Development
11.7 Sandoz
11.7.1 Sandoz Company Detail
11.7.2 Sandoz Business Overview
11.7.3 Sandoz Agoraphobia Introduction
11.7.4 Sandoz Revenue in Agoraphobia Business (2019-2024)
11.7.5 Sandoz Recent Development
11.8 Apotex
11.8.1 Apotex Company Detail
11.8.2 Apotex Business Overview
11.8.3 Apotex Agoraphobia Introduction
11.8.4 Apotex Revenue in Agoraphobia Business (2019-2024)
11.8.5 Apotex Recent Development
11.9 Mylan Pharmaceuticals
11.9.1 Mylan Pharmaceuticals Company Detail
11.9.2 Mylan Pharmaceuticals Business Overview
11.9.3 Mylan Pharmaceuticals Agoraphobia Introduction
11.9.4 Mylan Pharmaceuticals Revenue in Agoraphobia Business (2019-2024)
11.9.5 Mylan Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Agoraphobia Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Selective Serotonin Reuptake Inhibitors
1.2.3 Norepinephrine Reuptake Inhibitors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Agoraphobia Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Private clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Agoraphobia Market Perspective (2019-2030)
2.2 Agoraphobia Growth Trends by Region
2.2.1 Global Agoraphobia Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Agoraphobia Historic Market Size by Region (2019-2024)
2.2.3 Agoraphobia Forecasted Market Size by Region (2025-2030)
2.3 Agoraphobia Market Dynamics
2.3.1 Agoraphobia Industry Trends
2.3.2 Agoraphobia Market Drivers
2.3.3 Agoraphobia Market Challenges
2.3.4 Agoraphobia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Agoraphobia Players by Revenue
3.1.1 Global Top Agoraphobia Players by Revenue (2019-2024)
3.1.2 Global Agoraphobia Revenue Market Share by Players (2019-2024)
3.2 Global Agoraphobia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Agoraphobia Revenue
3.4 Global Agoraphobia Market Concentration Ratio
3.4.1 Global Agoraphobia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Agoraphobia Revenue in 2023
3.5 Agoraphobia Key Players Head office and Area Served
3.6 Key Players Agoraphobia Product Solution and Service
3.7 Date of Enter into Agoraphobia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Agoraphobia Breakdown Data by Type
4.1 Global Agoraphobia Historic Market Size by Type (2019-2024)
4.2 Global Agoraphobia Forecasted Market Size by Type (2025-2030)
5 Agoraphobia Breakdown Data by Application
5.1 Global Agoraphobia Historic Market Size by Application (2019-2024)
5.2 Global Agoraphobia Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Agoraphobia Market Size (2019-2030)
6.2 North America Agoraphobia Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Agoraphobia Market Size by Country (2019-2024)
6.4 North America Agoraphobia Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Agoraphobia Market Size (2019-2030)
7.2 Europe Agoraphobia Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Agoraphobia Market Size by Country (2019-2024)
7.4 Europe Agoraphobia Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Agoraphobia Market Size (2019-2030)
8.2 Asia-Pacific Agoraphobia Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Agoraphobia Market Size by Region (2019-2024)
8.4 Asia-Pacific Agoraphobia Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Agoraphobia Market Size (2019-2030)
9.2 Latin America Agoraphobia Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Agoraphobia Market Size by Country (2019-2024)
9.4 Latin America Agoraphobia Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Agoraphobia Market Size (2019-2030)
10.2 Middle East & Africa Agoraphobia Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Agoraphobia Market Size by Country (2019-2024)
10.4 Middle East & Africa Agoraphobia Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Agoraphobia Introduction
11.1.4 Eli Lilly Revenue in Agoraphobia Business (2019-2024)
11.1.5 Eli Lilly Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Detail
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Agoraphobia Introduction
11.2.4 Bristol-Myers Squibb Revenue in Agoraphobia Business (2019-2024)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Agoraphobia Introduction
11.3.4 AstraZeneca Revenue in Agoraphobia Business (2019-2024)
11.3.5 AstraZeneca Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Agoraphobia Introduction
11.4.4 Pfizer Revenue in Agoraphobia Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Agoraphobia Introduction
11.5.4 GlaxoSmithKline Revenue in Agoraphobia Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Johnson&Johnson
11.6.1 Johnson&Johnson Company Detail
11.6.2 Johnson&Johnson Business Overview
11.6.3 Johnson&Johnson Agoraphobia Introduction
11.6.4 Johnson&Johnson Revenue in Agoraphobia Business (2019-2024)
11.6.5 Johnson&Johnson Recent Development
11.7 Sandoz
11.7.1 Sandoz Company Detail
11.7.2 Sandoz Business Overview
11.7.3 Sandoz Agoraphobia Introduction
11.7.4 Sandoz Revenue in Agoraphobia Business (2019-2024)
11.7.5 Sandoz Recent Development
11.8 Apotex
11.8.1 Apotex Company Detail
11.8.2 Apotex Business Overview
11.8.3 Apotex Agoraphobia Introduction
11.8.4 Apotex Revenue in Agoraphobia Business (2019-2024)
11.8.5 Apotex Recent Development
11.9 Mylan Pharmaceuticals
11.9.1 Mylan Pharmaceuticals Company Detail
11.9.2 Mylan Pharmaceuticals Business Overview
11.9.3 Mylan Pharmaceuticals Agoraphobia Introduction
11.9.4 Mylan Pharmaceuticals Revenue in Agoraphobia Business (2019-2024)
11.9.5 Mylan Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Agoraphobia Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Selective Serotonin Reuptake Inhibitors
Table 3. Key Players of Norepinephrine Reuptake Inhibitors
Table 4. Key Players of Others
Table 5. Global Agoraphobia Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Agoraphobia Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Agoraphobia Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Agoraphobia Market Share by Region (2019-2024)
Table 9. Global Agoraphobia Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Agoraphobia Market Share by Region (2025-2030)
Table 11. Agoraphobia Market Trends
Table 12. Agoraphobia Market Drivers
Table 13. Agoraphobia Market Challenges
Table 14. Agoraphobia Market Restraints
Table 15. Global Agoraphobia Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Agoraphobia Market Share by Players (2019-2024)
Table 17. Global Top Agoraphobia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Agoraphobia as of 2023)
Table 18. Ranking of Global Top Agoraphobia Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Agoraphobia Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Agoraphobia Product Solution and Service
Table 22. Date of Enter into Agoraphobia Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Agoraphobia Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Agoraphobia Revenue Market Share by Type (2019-2024)
Table 26. Global Agoraphobia Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Agoraphobia Revenue Market Share by Type (2025-2030)
Table 28. Global Agoraphobia Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Agoraphobia Revenue Market Share by Application (2019-2024)
Table 30. Global Agoraphobia Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Agoraphobia Revenue Market Share by Application (2025-2030)
Table 32. North America Agoraphobia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Agoraphobia Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Agoraphobia Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Agoraphobia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Agoraphobia Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Agoraphobia Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Agoraphobia Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Agoraphobia Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Agoraphobia Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Agoraphobia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Agoraphobia Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Agoraphobia Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Agoraphobia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Agoraphobia Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Agoraphobia Market Size by Country (2025-2030) & (US$ Million)
Table 47. Eli Lilly Company Detail
Table 48. Eli Lilly Business Overview
Table 49. Eli Lilly Agoraphobia Product
Table 50. Eli Lilly Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 51. Eli Lilly Recent Development
Table 52. Bristol-Myers Squibb Company Detail
Table 53. Bristol-Myers Squibb Business Overview
Table 54. Bristol-Myers Squibb Agoraphobia Product
Table 55. Bristol-Myers Squibb Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 56. Bristol-Myers Squibb Recent Development
Table 57. AstraZeneca Company Detail
Table 58. AstraZeneca Business Overview
Table 59. AstraZeneca Agoraphobia Product
Table 60. AstraZeneca Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 61. AstraZeneca Recent Development
Table 62. Pfizer Company Detail
Table 63. Pfizer Business Overview
Table 64. Pfizer Agoraphobia Product
Table 65. Pfizer Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. GlaxoSmithKline Company Detail
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline Agoraphobia Product
Table 70. GlaxoSmithKline Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 71. GlaxoSmithKline Recent Development
Table 72. Johnson&Johnson Company Detail
Table 73. Johnson&Johnson Business Overview
Table 74. Johnson&Johnson Agoraphobia Product
Table 75. Johnson&Johnson Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 76. Johnson&Johnson Recent Development
Table 77. Sandoz Company Detail
Table 78. Sandoz Business Overview
Table 79. Sandoz Agoraphobia Product
Table 80. Sandoz Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 81. Sandoz Recent Development
Table 82. Apotex Company Detail
Table 83. Apotex Business Overview
Table 84. Apotex Agoraphobia Product
Table 85. Apotex Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 86. Apotex Recent Development
Table 87. Mylan Pharmaceuticals Company Detail
Table 88. Mylan Pharmaceuticals Business Overview
Table 89. Mylan Pharmaceuticals Agoraphobia Product
Table 90. Mylan Pharmaceuticals Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 91. Mylan Pharmaceuticals Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Agoraphobia Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Agoraphobia Market Share by Type: 2023 VS 2030
Figure 3. Selective Serotonin Reuptake Inhibitors Features
Figure 4. Norepinephrine Reuptake Inhibitors Features
Figure 5. Others Features
Figure 6. Global Agoraphobia Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Agoraphobia Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Private clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Agoraphobia Report Years Considered
Figure 12. Global Agoraphobia Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Agoraphobia Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Agoraphobia Market Share by Region: 2023 VS 2030
Figure 15. Global Agoraphobia Market Share by Players in 2023
Figure 16. Global Top Agoraphobia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Agoraphobia as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Agoraphobia Revenue in 2023
Figure 18. North America Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Agoraphobia Market Share by Country (2019-2030)
Figure 20. United States Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Agoraphobia Market Share by Country (2019-2030)
Figure 24. Germany Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Agoraphobia Market Share by Region (2019-2030)
Figure 32. China Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Agoraphobia Market Share by Country (2019-2030)
Figure 40. Mexico Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Agoraphobia Market Share by Country (2019-2030)
Figure 44. Turkey Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Eli Lilly Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 48. AstraZeneca Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 51. Johnson&Johnson Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 52. Sandoz Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 53. Apotex Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 54. Mylan Pharmaceuticals Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global Agoraphobia Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Selective Serotonin Reuptake Inhibitors
Table 3. Key Players of Norepinephrine Reuptake Inhibitors
Table 4. Key Players of Others
Table 5. Global Agoraphobia Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Agoraphobia Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Agoraphobia Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Agoraphobia Market Share by Region (2019-2024)
Table 9. Global Agoraphobia Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Agoraphobia Market Share by Region (2025-2030)
Table 11. Agoraphobia Market Trends
Table 12. Agoraphobia Market Drivers
Table 13. Agoraphobia Market Challenges
Table 14. Agoraphobia Market Restraints
Table 15. Global Agoraphobia Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Agoraphobia Market Share by Players (2019-2024)
Table 17. Global Top Agoraphobia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Agoraphobia as of 2023)
Table 18. Ranking of Global Top Agoraphobia Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Agoraphobia Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Agoraphobia Product Solution and Service
Table 22. Date of Enter into Agoraphobia Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Agoraphobia Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Agoraphobia Revenue Market Share by Type (2019-2024)
Table 26. Global Agoraphobia Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Agoraphobia Revenue Market Share by Type (2025-2030)
Table 28. Global Agoraphobia Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Agoraphobia Revenue Market Share by Application (2019-2024)
Table 30. Global Agoraphobia Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Agoraphobia Revenue Market Share by Application (2025-2030)
Table 32. North America Agoraphobia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Agoraphobia Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Agoraphobia Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Agoraphobia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Agoraphobia Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Agoraphobia Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Agoraphobia Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Agoraphobia Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Agoraphobia Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Agoraphobia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Agoraphobia Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Agoraphobia Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Agoraphobia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Agoraphobia Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Agoraphobia Market Size by Country (2025-2030) & (US$ Million)
Table 47. Eli Lilly Company Detail
Table 48. Eli Lilly Business Overview
Table 49. Eli Lilly Agoraphobia Product
Table 50. Eli Lilly Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 51. Eli Lilly Recent Development
Table 52. Bristol-Myers Squibb Company Detail
Table 53. Bristol-Myers Squibb Business Overview
Table 54. Bristol-Myers Squibb Agoraphobia Product
Table 55. Bristol-Myers Squibb Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 56. Bristol-Myers Squibb Recent Development
Table 57. AstraZeneca Company Detail
Table 58. AstraZeneca Business Overview
Table 59. AstraZeneca Agoraphobia Product
Table 60. AstraZeneca Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 61. AstraZeneca Recent Development
Table 62. Pfizer Company Detail
Table 63. Pfizer Business Overview
Table 64. Pfizer Agoraphobia Product
Table 65. Pfizer Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. GlaxoSmithKline Company Detail
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline Agoraphobia Product
Table 70. GlaxoSmithKline Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 71. GlaxoSmithKline Recent Development
Table 72. Johnson&Johnson Company Detail
Table 73. Johnson&Johnson Business Overview
Table 74. Johnson&Johnson Agoraphobia Product
Table 75. Johnson&Johnson Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 76. Johnson&Johnson Recent Development
Table 77. Sandoz Company Detail
Table 78. Sandoz Business Overview
Table 79. Sandoz Agoraphobia Product
Table 80. Sandoz Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 81. Sandoz Recent Development
Table 82. Apotex Company Detail
Table 83. Apotex Business Overview
Table 84. Apotex Agoraphobia Product
Table 85. Apotex Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 86. Apotex Recent Development
Table 87. Mylan Pharmaceuticals Company Detail
Table 88. Mylan Pharmaceuticals Business Overview
Table 89. Mylan Pharmaceuticals Agoraphobia Product
Table 90. Mylan Pharmaceuticals Revenue in Agoraphobia Business (2019-2024) & (US$ Million)
Table 91. Mylan Pharmaceuticals Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Agoraphobia Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Agoraphobia Market Share by Type: 2023 VS 2030
Figure 3. Selective Serotonin Reuptake Inhibitors Features
Figure 4. Norepinephrine Reuptake Inhibitors Features
Figure 5. Others Features
Figure 6. Global Agoraphobia Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Agoraphobia Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Private clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Agoraphobia Report Years Considered
Figure 12. Global Agoraphobia Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Agoraphobia Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Agoraphobia Market Share by Region: 2023 VS 2030
Figure 15. Global Agoraphobia Market Share by Players in 2023
Figure 16. Global Top Agoraphobia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Agoraphobia as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Agoraphobia Revenue in 2023
Figure 18. North America Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Agoraphobia Market Share by Country (2019-2030)
Figure 20. United States Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Agoraphobia Market Share by Country (2019-2030)
Figure 24. Germany Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Agoraphobia Market Share by Region (2019-2030)
Figure 32. China Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Agoraphobia Market Share by Country (2019-2030)
Figure 40. Mexico Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Agoraphobia Market Share by Country (2019-2030)
Figure 44. Turkey Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Agoraphobia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Eli Lilly Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 48. AstraZeneca Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 51. Johnson&Johnson Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 52. Sandoz Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 53. Apotex Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 54. Mylan Pharmaceuticals Revenue Growth Rate in Agoraphobia Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232